drugset / Trial / NCT07473427
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese Children
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This is a single armed, Phase 3 study to assess the immunogenicity and safety of the varicella vaccine manufactured by Sinovac. A total of 300 healthy participants aged 1-12 years will be enrolled. All participants will receive a single dose of varicella vaccine manufactured by Sinovac.
Timeline
- Start
- 2026-06-15
- Primary completion
- 2026-08-01
- Completion
- 2026-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varicella vaccine | Vaccine | — | — |